Back to search results

Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects

Abroad (travel likely)RecruitingPHASE1

Conditions

Depression - Major Depressive Disorder · Anhedonia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General Psychiatry, Vienna, State of Vienna, Austria

    Contact: Study coordinator (Marie Spies, Priv.-Doz. DDr.) · marie.spies@meduniwien.ac.at · +43 1 40400
    Contact: Study coordinator (Clemens Schmidt, MD) · clemens.schmidt@meduniwien.ac.at · +43 1 40400
    Contact: Principal Investigator (Marie Spies, Priv.-Doz. DDr.)
    Clemens Schmidt, MD (Sub-investigator)
    Benjamin Eggerstorfer, MD (Sub-investigator)
Study leads

  • Marie Spies, Priv.-Doz. DDr.

    Principal Investigator

    Medical University of Vienna, Department of Psychiatry and Psychotherapy, Division of General Psychiatry

View source on ClinicalTrials.gov(opens in a new tab)